Skip to main content
Retour
Watch Compare

Tenon Medical, Inc.

Qualité des données : 100%
Également cotée sous TNONW Nasdaq
TNON
Nasdaq Manufacturing Measuring & Analyzing Instruments
0,73 €
▼ 0,01 € (-1,35%)
Cap. Boursière: 8,26 M
Prix
0,73 €
Cap. Boursière
8,26 M
Fourchette du Jour
0,72 € — 0,74 €
Fourchette 52 Semaines
0,64 € — 2,48 €
Volume
57 520
Ouverture 0,73 €
Moyenne 50J / 200J
0,80 €
8,36% below
Moyenne 50J / 200J
1,06 €
31,04% below

Quick Summary

Points Clés

Negative free cash flow of -11,02 M
Capital efficient — spends only 6,92% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)20,35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-218,16%
En dessous de la moyenne du secteur (-53,41%)
ROIC-127,31%
Net Margin-318,36%
Op. Margin-324,34%

Sécurité

Debt / Equity
N/A
Current Ratio2,15
Interest Coverage-376,24

Valorisation

PE (TTM)
-0,66
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,72
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,7 -1,5
P/B 1,7 1,6
ROE % -218,2 -53,4
Net Margin % -318,4 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 20,35% Revenue Growth (3Y) 16,06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3,94 M Net Income (TTM) -12,56 M
ROE -218,16% ROA -116,91%
Gross Margin 59,79% Operating Margin -324,34%
Net Margin -318,36% Free Cash Flow (TTM) -11,02 M
ROIC -127,31% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,15
Interest Coverage -376,24 Asset Turnover 0,37
Working Capital 3,50 M Tangible Book Value 1,89 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,66 Forward P/E N/A
P/B Ratio 1,72 P/S Ratio 2,09
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -133,37%
Market Cap 8,26 M Enterprise Value 4,82 M
Per Share
EPS (Diluted TTM) -1,70 Revenue / Share 0,35
FCF / Share -0,98 OCF / Share -0,95
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6,92% FCF Conversion 87,75%
SBC-Adj. FCF -13,28 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 3,94 M 3,28 M 2,93 M 691 000,0
Net Income -12,56 M -13,67 M -15,58 M -18,92 M
EPS (Diluted) -1,70 -11,26 -8,59 -2,36
Gross Profit 2,36 M 1,71 M 1,24 M -641 000,0
Operating Income -12,79 M -13,77 M -15,73 M -18,73 M
EBITDA — — — —
R&D Expenses 2,15 M 2,60 M 3,16 M 2,83 M
SG&A Expenses — — — —
D&A 262 000,0 408 000,0 199 000,0 —
Interest Expense 34 000,0 34 000,0 21 000,0 354 000,0
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 10,76 M 9,84 M 6,35 M 11,09 M
Total Liabilities 5,72 M 3,87 M 5,57 M 4,84 M
Shareholders' Equity 5,04 M 5,97 M 778 000,0 6,25 M
Total Debt — — — —
Cash & Equivalents 3,76 M 6,54 M 2,43 M 2,13 M
Current Assets 6,77 M 8,21 M 3,89 M 9,35 M
Current Liabilities 3,21 M 1,87 M 3,14 M 2,53 M